These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21636146)

  • 1. A meta-analysis of randomized trials of triple versus dual antiplatelet therapy after stent-based percutaneous coronary intervention.
    Takagi H; Umemoto T
    Int J Cardiol; 2011 Jul; 150(2):228-30. PubMed ID: 21636146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Percutaneous coronary intervention and stent thrombosis].
    Sugaya T; Igarashi K
    Nihon Rinsho; 2011 Feb; 69(2):275-9. PubMed ID: 21387676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.
    Acharjee S; Cannon CP
    Crit Pathw Cardiol; 2010 Dec; 9(4):203-6. PubMed ID: 21119338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent thrombosis: an overview.
    Centemero MP; Stadler JR
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):599-615. PubMed ID: 22651836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on dual antiplatelet therapy for percutaneous coronary intervention.
    Prasad A; Holmes DR
    Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
    Di Sciascio G; Patti G; Pasceri V; Colonna G; Mangiacapra F; Montinaro A;
    Eur Heart J; 2010 Jun; 31(11):1337-43. PubMed ID: 20363764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of bare metal stent in drug eluting stent era].
    Takizawa K; Inoue N
    Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of platelet function in patients on antiplatelet therapy undergoing cardiac surgery: a review.
    Patni R; Nawaz MA; Macys A; Chan KM; Punjabi P
    Heart Lung Circ; 2012 Aug; 21(8):455-62. PubMed ID: 22503172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life management of dual antiplatelet therapy interruption: the REGINA survey.
    Collet JP; Aout M; Alantar A; Coriat P; Napoléon B; Thomas D; Trosini-Desert V; Tucas G; Vicaut E; Montalescot G
    Arch Cardiovasc Dis; 2009 Oct; 102(10):697-710. PubMed ID: 19913771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjunctive pharmacologic therapy in percutaneous coronary intervention: part I antiplatelet therapy.
    Kim SJ; Giugliano RP; Jang IK
    Coron Artery Dis; 2011 Mar; 22(1):100-12. PubMed ID: 20926950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G; Lee MS
    Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
    Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.